Loading...Loading...Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant DepressionPartners Beckley Psytech and atai Life Sciences ATAI have jointly announced positive initial results from a Phase 2a study of Beckley’s novel formulation of 5-MeO-DMT in Treatment Resistant Depression (TRD.) BPL-003 is a synthetic and patent-protected benzoate salt formulation of 5-MeO-DMT (aka mebufotenin) designed for intranasal administration.

正在加载。。。正在加载。。。鼻内5-MeO-DMT临床试验为治疗耐药性抑郁症提供了希望合作伙伴Beckley Psytech和atai Life Sciences atai联合宣布了Beckley新型5-MeO-DMT治疗耐药性抑郁症（TRD）的2a期研究的积极初步结果。BPL-003是一种合成且受专利保护的5-MeO-DMT（又名mebufotenin）苯甲酸盐制剂，设计用于鼻内给药。

The open-label study assessed safety, tolerability and efficacy of the compound at a single 10mg dose, alongside psychological support, in patients with moderate-to-severe TRD (who withdrew from concomitant antidepressants.) Learn more.Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health ConditionsProviders at Utah’s two largest healthcare systems may now treat patients with psilocybin and MDMA as part of a pilot program created by a proposal-turned-law that will take effect as early as May 1, 2024. The program, open to providers at the University of Utah Health and Intermountain Health, will last three years.

这项开放标签研究评估了该化合物单次10mg剂量的安全性，耐受性和有效性，以及心理支持，用于中度至重度TRD患者（退出伴随抗抑郁药）。了解更多信息。犹他州医院很快将为精神健康状况提供Psilocybin和MDMA治疗。犹他州两个最大的医疗保健系统的提供者现在可能会治疗Psilocybin和MDMA患者，这是一项由提案转化的法律创建的试点计划的一部分，该计划最早将于2024年5月1日生效。该计划将向犹他大学健康与山间健康学院的提供者开放，为期三年。

Next, the Legislature will decide whether or not to resume it. Learn more.Elon Musk On Ketamine And Investors’ Value: ‘If There Is Something I’m Taking, I Should Keep Taking It’Elon Musk once again made the case for using psychedelics. In a new interview with former CNN anchor Don Lemon, the business magnate said prescription ketamine has helped him with occasional depressive episodes.

接下来，立法机构将决定是否恢复。了解更多信息。埃隆·马斯克（ElonMusk）谈到氯胺酮和投资者的价值：“如果我服用了什么，我应该继续服用。”埃隆·马斯克（ElonMusk）再次提出使用迷幻药的理由。在接受前美国有线电视新闻网（CNN）主持人唐·莱蒙（DonLemon）的最新采访时，这位商业巨头表示，处方氯胺酮帮助他偶尔出现抑郁发作。

He also suggested that taking the ketamine has also been beneficial for investors in his companies..

他还建议服用氯胺酮对其公司的投资者也有好处。。

The Tesla TSLA and SpaceX chief executive says he takes “a small amount once every other week,” and sometimes less frequently, to treat the “chemical tides” that can trigger his depression. “Ketamine is helpful for getting one out of a negative frame of mind,” Musk told Lemon. Keep reading.Loading...Loading...Do Meta And Other Platforms Play A Role In Illicit Drug Sales? US Prosecutors Intend To Find OutProsecutors in Virginia are probing whether Facebook-parent Meta’s social media platforms Facebook and Instagram are facilitating and profiting from the illegal sale of drugs, according to a Saturday Wall Street Journal report.Led by Assistant U.S.

特斯拉TSLA和SpaceX首席执行官表示，他“每隔一周服用一次少量”，有时服用频率较低，以治疗可能引发抑郁症的“化学潮汐”。马斯克告诉莱蒙：“氯胺酮有助于让人摆脱消极的心态。”。继续阅读。正在加载。。。正在加载。。。Meta和其他平台是否在非法药物销售中发挥作用？据《星期六华尔街日报》报道，美国检察官打算在弗吉尼亚州寻找外包者，他们正在调查脸书母公司Meta的社交媒体平台脸书（Facebook）和Instagram是否在为非法毒品销售提供便利并从中获利。由美国助理领导。

Attorney Randy Ramseyer, the investigation includes delving into whether Meta META failed to adequately remove drug-related content from its platforms. Read more.Podcast: LSD ‘Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics’ Says MindMed’s R. BarrowWelcome to a new episode of the Benzinga Psychedelics Podcast where we're joined by Robert Barrow, CEO of Mind Medicine (MindMed) MNMD, which has taken the development of LSD-based therapy to new heights.

律师兰迪·拉姆西耶（RandyRamseyer）表示，调查包括探究Meta-Meta是否未能从其平台上充分删除与毒品相关的内容。阅读更多。播客：MindMed的R.Barrow说，迷幻药“值得在迷幻药的道路上重新占据领先地位”，欢迎收看Benzinga迷幻药播客的新一集，MindMed MNMD首席执行官罗伯特·巴罗（RobertBarrow）加入了我们的行列，他将基于迷幻药的疗法的发展推向了新的高度。

The biopharma company recently obtained a “breakthrough therapy” designation for the treatment of generalized anxiety from the U.S. Food and Drug Administration (FDA.) Find out more and listen here.The Milestone Round.

这家生物制药公司最近从美国食品和药物管理局（FDA）获得了治疗广泛性焦虑症的“突破疗法”称号。了解更多信息，请点击此处收听。里程碑回合。

PharmAla’s MDXXF novel MDMA mixture awarded US patent, enabling IP protection and further development.

PharmAla的MDXXF新型MDMA混合物授予美国专利，实现了知识产权保护和进一步发展。

Two top biotechs forge MDMA supply deals for an expanding research field.

两家顶尖的生物技术公司为不断扩大的研究领域达成了MDMA供应协议。

Enveric Biosciences ENVB optimistic on Q4 and full-year results: ‘Psychedelic-inspired’ meds for future growth.

Enveric Biosciences ENVB对第四季度和全年业绩持乐观态度：“迷幻药激发”药物对未来增长的影响。

Congress discusses remaining FY2024 spending bill with provisions on cannabis sales and psychedelic clinical trials.

国会讨论了剩余的2024财年支出法案，其中包括大麻销售和迷幻药临床试验的规定。

VA calls for amending medical marijuana bill, rejects psychedelics proposal.

弗吉尼亚州呼吁修改医用大麻法案，拒绝迷幻药提案。

Reform update: Task forces in three states, decrim no-go, Arizona psilocybin centers, Utah and more.

改革更新：三个州的特别工作组，decrim no go，Arizona-psilocybin中心，犹他州等等。

Goodbye to weed posts in Colorado? Lawmakers target social media promotion of cannabis and psychedelics.

再见科罗拉多州的杂草帖子？立法者的目标是在社交媒体上推广大麻和迷幻药。

Psychedelic-assisted therapy advancements create a new horizon for mental health in Colorado.

迷幻药辅助治疗的进步为科罗拉多州的心理健康创造了新的视野。

At 77, cannabis champion Dana Beal fights Idaho laws to push legalization in hostile territory.

77岁的大麻冠军达娜·比尔（DanaBeal）反对爱达荷州法律，在敌对地区推行合法化。

This biotech is creating targeted radiotherapeutics for some of the deadliest cancers.

这项生物技术正在为一些最致命的癌症创造有针对性的放射疗法。

See Also: Prior Edition Of ‘Psyched’Psychedelics ETF's Weekly PerformanceAdvisorShares Psychedelics ETF PSIL opened Monday, March 25 at $1.45, following openings at $1.50, $1.65 and $1.58 (March 18, 11 and 4, respectively.)On Thursday, March 28, it closed at $1.49, following prior closings at $1.44, $1.53 and $1.64 (March 22, 15 and 8, respectively.)The week's highest within open market hours was $1.49, vs.

另请参见：《迷幻迷幻药》ETF前一版的每周表现维索尔股份迷幻药ETF PSIL于3月25日星期一以1.45美元开盘，此前开盘价分别为1.50美元、1.65美元和1.58美元（分别为3月18日、11日和4日）。3月28日星期四，该基金收盘价为1.49美元，此前收盘价分别为1.44美元、1.53美元和1.64美元（分别为3月22日、15日和8日）。本周公开市场时间内的最高价格为1.49美元，而。

prior highest points $1.55, $1.65 and $1.78.Week's lowest (open market hours) was $1.42, vs. prior lowest points $1.41, $1.46 and $1.44. Highest Trading Psychedelics Stocks Thursday, March 28 Close.

之前的最高点分别为1.55美元、1.65美元和1.78美元。本周的最低点（公开市场时间）为1.42美元，而之前的最低点分别为1.41美元、1.46美元和1.44美元。迷幻药类股票的交易价格最高，3月28日周四收盘。

GH Research GHRS closed at $10.66, similar to the immediately prior week closings $10.54 and $10.91 (March 22 and 15) and jumping from and $8.08 on March 8.

GH Research GHRS收盘价为10.66美元，与前一周收盘价10.54美元和10.91美元（3月22日和15日）相似，并从3月8日的8.08美元跃升。

Mind Medicine (MindMed) MNMD closed at $9.53, up and running as per prior closings at $9.85, $9.10 and $9.50.

Mind Medicine（MindMed）MNMD收盘价为9.53美元，按照之前的收盘价分别上涨至9.85美元、9.10美元和9.50美元。

COMPASS Pathways CMPS closed at $8.33, sustaining the descending trend as per prior closings at $8.99, $9.90 and $10.88.

COMPASS Pathways CMPS收盘价为8.33美元，维持了之前收盘价8.99美元、9.90美元和10.88美元的下降趋势。

Incannex Healthcare IXHL closed at $3.60, a recovery from prior closings at $2.82 and $3.25, yet still not at $4.20 as three weeks ago.

Incanex Healthcare IXHL收于3.60美元，较之前的收盘价2.82美元和3.25美元有所回升，但仍没有三周前的4.20美元。

Atai Life Sciences ATAI closed at $1.93, vs. prior closings at $1.63, $1.75 and $2.11.

Atai Life Sciences Atai收于1.93美元，而之前的收盘价分别为1.63美元、1.75美元和2.11美元。

Silo Pharma SILO closed at $1.92, sustaining the trend as per prior closings at $1.86, $1.84 and $1.61.

思洛制药（Silo Pharma）思洛（Silo）收盘价为1.92美元，维持了之前收盘价1.86美元、1.84美元和1.61美元的趋势。

Lucy Scientific LSDI closed at $1.39, a similar trend as per prior closings at $1.38, $1.25 and $1.70.

Lucy Scientific LSDI收盘价为1.39美元，与之前收盘价1.38美元、1.25美元和1.70美元的走势相似。

Bright Minds Biosciences DRUG closed at $1.20, still falling as per prior closings at $1.22, $1.31 and $1.58.

Bright Minds Biosciences药品收盘价为1.20美元，与之前的收盘价相比仍在下跌，分别为1.22美元、1.31美元和1.58美元。

Clearmind Medicine CMND closed at $1.15, also still falling vs. prior closings at $1.18, $1.27 and $1.38.

Clearmind Medicine CMND收于1.15美元，与之前的收盘价1.18美元、1.27美元和1.38美元相比仍在下跌。

Enveric Biosciences ENVB closed at $1.03, vs. prior closings at $ 1.13, $1.07 and $1.46.

Enveric Biosciences ENVB收于1.03美元，而之前的收盘价分别为1.13美元、1.07美元和1.46美元。

Stock trading numbers above according to Benzinga Pro, our all-the-information-you-need streaming platform helping you invest smarter – Come join us and see for yourself!Loading...Loading...

以上股票交易数字根据Benzinga Pro，我们提供您所需的所有信息流平台，帮助您更明智地投资-欢迎加入我们，亲自查看！正在加载。。。正在加载。。。